The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated to include a 90-second intravenous (IV) push loading dose.. Trogarzo, a CD4-directed post-attachment HIV-1 inhibitor ...

The Food and Drug Administration (FDA) has approved Trogarzo ® (ibalizumab-uiyk) for administration by intravenous (IV) push for maintenance dosing.. Trogarzo is a CD4-directed post-attachment ...

An intravenous (IV) injection is a fast and accurate way of administering a medication. ... Push a small plastic catheter over the needle and into the vein. Remove the needle, ...

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...

The Trogarzo® loading dose can also be administered as an undiluted intravenous (IV) push over 90 seconds, and the maintenance dose can be administered as an undiluted IV push over 30 seconds ...

Reduces maintenance dose from a 15-minute IV infusion to a 30-second, undiluted IV push every two weeksSafety profile of Trogarzo® IV push similar to that of IV infusionNew method of ...

Release Summary. Vizient has published a conservation guide for adult and pediatric IV push medications to help mitigate potential hurricane-caused supply disruptions.